Cardiovascular Diseases study: Early Intervention
Official title Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
ClinicalTrials.gov ID: NCT05325034
What this study is testing
- What it's testing
- This study is testing whether a guideline‑based approach to lower cholesterol works better than usual care for people with heart disease.
- Who it's for
- You may be able to join if you are a patient in Asia-Pacific with high cholesterol and a history of heart problems.
- What's involved
- You would be recruited while in the hospital and then randomly assigned to receive a new cholesterol‑lowering plan either right away or after six months. The plan includes medication, diet advice, and follow‑up visits.
- Time commitment
- The study lasts about six months, with visits at the start, at six months, and possibly additional check‑ins.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age
- Admission for Type I myocardial infarction
You likely can't join if
- LDL \<1.4mmol/L at baseline
- Unable to provide contact details of primary care physician/general practitioner
- Unable to provide written informed consent.
- Unlikely to survive \>12 months
The study team makes the final eligibility decision.
Where it is enrolling
- Wollongong, New South Wales, Australia
- Cairns, Queensland, Australia
- Clayton, Victoria, Australia
- Melbourne, Victoria, Australia
- Dalian, Liaoning, China
- New Delhi, India
- Osaka, Japan
- Kuala Lumpur, Malaysia
- Singapore, Singapore
- Tainan, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Wollongong, New South Wales, Australia; Cairns, Queensland, Australia; Clayton, Victoria, Australia; Melbourne, Victoria, Australia; Dalian, Liaoning, China; New Delhi, India and 4 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.